{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:21:41Z","timestamp":1788013301316,"version":"build-2784847793"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/ico.0b013e31826a80ea","type":"journal-article","created":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T11:42:01Z","timestamp":1349264521000},"page":"S25-S31","source":"Crossref","is-referenced-by-count":29,"title":["Effectiveness of Topical Infliximab in a Mouse Model of Experimental Dry Eye"],"prefix":"10.1097","volume":"31","author":[{"given":"Zhengri","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Jin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Chul","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210204","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":". The definition of classification of dry eye diseases: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007).","volume":"5","author":"Lemp","year":"2007","journal-title":"Ocul Surf"},{"key":"R2-5-20210204","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1542-0124(12)70148-9","article-title":"Inflammation in dry eye.","volume":"2","author":"Stern","year":"2004","journal-title":"Ocul Surf"},{"issue":"suppl 1","key":"R3-5-20210204","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/ICO.0b013e31817f4075","article-title":". Epithelial-immune cell interaction in dry eye.","volume":"27","author":"Pflugfelder","year":"2008","journal-title":"Cornea"},{"key":"R4-5-20210204","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1542-0124(12)70297-5","article-title":"Stern ME; Symposium participants. Immunoregulation on the ocular surface: 2nd Cullen Symposium.","volume":"7","author":"Pflugfelder","year":"2009","journal-title":"Ocul Surf"},{"key":"R5-5-20210204","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1167\/iovs.07-0002","article-title":". Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL6 mice: effects of desiccating stress.","volume":"48","author":"Yoon","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-5-20210204","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1167\/iovs.09-3425","article-title":". Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome.","volume":"51","author":"Yoon","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-5-20210204","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mi.2009.5","article-title":". IL-17 disrupts corneal barrier following desiccating stress.","volume":"2","author":"De Paiva","year":"2009","journal-title":"Mucosal Immunol"},{"key":"R8-5-20210204","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","article-title":". Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogrens syndrome keratoconjunctivitis sicca.","volume":"19","author":"Pflugfelder","year":"1999","journal-title":"Curr Eye Res"},{"key":"R9-5-20210204","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","article-title":". Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.","volume":"26","author":"Yoon","year":"2007","journal-title":"Cornea"},{"key":"R10-5-20210204","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/ICO.0b013e3181a16578","article-title":". Analysis of inflammatory cytokines in the tears of dry eye patients.","volume":"28","author":"Massingale","year":"2009","journal-title":"Cornea"},{"key":"R11-5-20210204","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2008.08.032","article-title":". Tear cytokine profiles in dysfunctional tear syndrome.","volume":"147","author":"Lam","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R12-5-20210204","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":". Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomized controlled trial.","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"},{"key":"R13-5-20210204","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.20217","article-title":". Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo controlled, 52-week trial.","volume":"50","author":"Keystone","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R14-5-20210204","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/art.20568","article-title":". Combination of infliximab and methotrexate therapy for early rheumatoid arthritis.","volume":"50","author":"St Clair","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R15-5-20210204","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archopht.123.7.903","article-title":". A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.","volume":"123","author":"Suhler","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R16-5-20210204","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archopht.122.6.845","article-title":". Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.","volume":"122","author":"Murphy","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R17-5-20210204","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","article-title":". Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.","volume":"111","author":"Murphy","year":"2004","journal-title":"Ophthalmology"},{"key":"R18-5-20210204","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0161-6420(03)00406-8","article-title":". Infliximab in the treatment of refractory posterior uveitis.","volume":"110","author":"Joseph","year":"2003","journal-title":"Ophthalmology"},{"key":"R19-5-20210204","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/ICO.0b013e318181a84f","article-title":"Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-up.","volume":"28","author":"Odorcic","year":"2009","journal-title":"Cornea"},{"key":"R20-5-20210204","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00003226-200305000-00012","article-title":". Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis.","volume":"22","author":"Zhu","year":"2003","journal-title":"Cornea"},{"key":"R21-5-20210204","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W","article-title":". Infliximab in patients with primary Sjogrens syndrome: a pilot study.","volume":"44","author":"Steinfeld","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R22-5-20210204","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1002\/art.10674","article-title":"Infliximab in primary Sjogrens syndrome: one-year followup.","volume":"46","author":"Steinfeld","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R23-5-20210204","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.20146","article-title":". Inefficacy of infliximab in primary Sjogrens syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogrens Syndrome (TRIPSS).","volume":"50","author":"Mariette","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R24-5-20210204","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.20299","article-title":". Etanercept in Sjogrens syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.","volume":"50","author":"Sankar","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R25-5-20210204","first-page":"96","article-title":". Etanercept in the treatment of patients with primary Sjogrens syndrome: a pilot study.","volume":"31","author":"Zandbelt","year":"2004","journal-title":"J Rheumatol"},{"key":"R26-5-20210204","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/ard.2007.077891","article-title":". Lack of efficacy of etanercept in Sjogren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.","volume":"67","author":"Moutsopoulos","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R27-5-20210204","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","article-title":". Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.","volume":"83","author":"De Paiva","year":"2006","journal-title":"Exp Eye Res"},{"key":"R28-5-20210204","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1167\/iovs.07-0069","article-title":". Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma.","volume":"48","author":"De Paiva","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R29-5-20210204","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.4049\/jimmunol.176.7.3950","article-title":". Desiccating stress induces T cell-mediated Sjogrens syndrome-like lacrimal keratoconjunctivitis.","volume":"176","author":"Niederkorn","year":"2006","journal-title":"J Immunol"},{"key":"R30-5-20210204","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaut.2007.09.003","article-title":". Desiccating environmental stress exacerbates autoimmune lacrimal keratoconjunctivitis in non-obese diabetic mice.","volume":"30","author":"Yoon","year":"2008","journal-title":"J Autoimmun"},{"key":"R31-5-20210204","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.icl.0000224360.10319.b1","article-title":"Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice.","volume":"32","author":"Villareal","year":"2006","journal-title":"Eye Contact Lens"},{"key":"R32-5-20210204","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1167\/iovs.05-1281","article-title":". Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline.","volume":"47","author":"De Paiva","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R33-5-20210204","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2009.181","article-title":"Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.","volume":"5","author":"Taylor","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"R34-5-20210204","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1084\/jem.20072707","article-title":". Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells.","volume":"205","author":"Notley","year":"2008","journal-title":"J Exp Med"},{"key":"R35-5-20210204","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis.","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"R36-5-20210204","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/1756283X10373176","article-title":"Anti-adhesion molecule therapy for inflammatory bowel disease.","volume":"3","author":"Ghosh","year":"2010","journal-title":"Therap Adv Gastroenterol"},{"key":"R37-5-20210204","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.clim.2011.01.015","article-title":". Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues.","volume":"139","author":"Bose","year":"2011","journal-title":"Clin Immunol"},{"key":"R38-5-20210204","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1186\/ar2888","article-title":". Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjogrens syndrome.","volume":"11","author":"Vosters","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"R39-5-20210204","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1167\/iovs.11-7231","article-title":". Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress.","volume":"52","author":"Yoon","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R40-5-20210204","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/372560a0","article-title":". Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice.","volume":"372","author":"Erickson","year":"1994","journal-title":"Nature"},{"key":"R41-5-20210204","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1074-7613(00)00041-8","article-title":"Signaling by the TNF receptor superfamily and T cell homeostasis.","volume":"13","author":"Chan","year":"2000","journal-title":"Immunity"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-201211001-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:17:17Z","timestamp":1786047437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-201211001-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":41,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31826a80ea","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}